II02801 IC261(10mM in DMSO,Sterile) 细胞周期 索莱宝产品图

II02801 IC261(10mM in DMSO,Ste

rile) 细胞周期 索莱宝
收藏
  • ¥1600
  • Solarbio已认证
  • 北京
  • II02801
  • 2026年05月21日
    avatar
    品牌商
    14钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      Stroe at -20℃,6 months.

    • 保质期

      Stroe at -20℃,6 months.

    • 英文名

      IC261(10mM in DMSO,Sterile)

    • 库存

      现询

    • 供应商

      北京索莱宝科技有限公司

    • CAS号

      186611-52-9

    • 规格

      1ml

    基本信息
    CASNo.186611-52-9
    英文名称IC261(10mM in DMSO,Sterile)
    分子式C18H17NO4
    分子量311.33
    溶解性请根据自己的实验要求使用。
    外观(性状)无菌溶液
    储存条件Stroe at -20℃,6 months.
    靶点Casein Kinase(CK)
    通路Cell Cycle;DNA Damage/DNA Repair; Stem Cells
    背景说明IC261 是一种选择性的ATP 竞争性的 CK1 抑制剂。
    生物活性IC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 μM, 1 μM, 16 μM for Ckiδ, Ckiε and Ckiα1, respectively.[1-3]
    In VitroIC261 is a selective, ATP-competitive CK1 inhibitor, with IC50s of 1 μM, 1 μM, 16 μM for Ckiδ, Ckiε and Ckiα1, respectively. IC261 is less active on PKA, p34cdc2, and p55fyn (IC50s > 100 μM)[1]. IC261 induces mitotic arrest, spindle defects and centrosome amplification in AC1-M88 cells. IC261 (1?μM) increases G2/M cells after 12?h, and causes cell death at 24 h in AC1-M88 cells. IC261 (1?μM) also induces apoptosis in the extravillous trophoblast hybrid cells[2]. IC261 (1.25 μM) suppresses the proliferation of several pancreatic tumour cell lines, including ASPC-1, BxPc3, Capan-1, Colo357, MiaPaCa-2, Panc1, Panc89, PancTu-1 and PancTu-2 cells. IC261 (1.25 μM) specifically enhances CD95-mediated apoptosis of pancreatic tumour cells[3].
    细胞实验IC261 (20.5 mg/kg) inhibits tumor growth of PancTu-2 cells in SCID mice, downregulates several anti-apoptotic proteins, such as CK1δ/?, KRAS, and IL6 and upregulates p21, ATM, CHEK1 and STAT1 in mice[3].
    细胞实验Human extravillous trophoblast cells irreversibly leave the cell cycle and die when isolated from its natural extracellular matrix. The cell line AC1-M88 is employed in vitro experiments. This cell line is generated by fusion of extravillous trophoblasts with AC1-1. Cells are grown in DMEM (CV-1) or DMEM/F-12 (AC1-M88) medium supplemented with 10% fetal calf serum (FCS) at 37°C in a humidified 5% CO2 atmosphere. Where indicated, cells are γ-irradiated with 5?Gy and harvested at the given time points for western blot analysis, treated with 1?μM IC261 or 0.4?μM nocodazole for 12?h and fixed for immunofluorescence analysis, or treated with 1?μM IC261 and fixed for flow cytometrical analysis or lysed for western blot analysis at the indicated time points. IC261 and nocodazole are dissolved in DMSO as stock solutions (25 and 10?mM, respectively), and control cells are treated with 0.004% DMSO. For immunocytochemistry, the cells are grown on coverslips and are treated with methanol (?20°C) for 5?min, followed by acetone (?20°C) for 20-30?s prior to being used for immunocytochemical detection[2].
    动物实验Five million PancTu-1 cells resuspended in 100 μL of a solution containing 50% Matrigel and 50% DMEM/RPMI-1640 (1:1) are injected into the dorsolateral site of 6-week-old C.B-17/IcrHsd-scid-bg mice. After 17 days, mice are randomised to the control group (n?=?5), the IC261 treatment group (n?=?5), the gemcitabine group (n?=?5) and to the IC261/gemcitabine group (n?=?5). Injection of dimethylsulfoxide (DMSO; control group), IC261 (20.5 mg/kg), gemcitabine (0.6 mg/kg) alone or in combination (20.5 mg/kg IC261/0.6 mg/kg gemcitabine) (treatment groups) is performed daily for 8 days. Mice are sacrificed by asphyxiation with CO2 the day after the last treatment. Tumours are measured before and during treatment. Finally, the tumours are excised, measured, weighed and fixed in formalin or shock frozen. Tumour volume is calculated according to the formula for a rotational ellipsoid (length × height × width × 0.5236)[3].
    激酶实验Casein kinase activity is assayed at 37°C. The standard reaction (40 μL) contains 25 mM 2-(N-morpholino)ethanesulfonic acid, pH 6.5, 50 mM NaCl, 15 mM MgCl2, 2 mg/mL casein, 2 mM EGTA, 100 μM [γ-32P]ATP (100-400 cpm/pmol). Initial velocity measurements are carried out in duplicate with ATP as the varied substrate. Kinetic constants and their standard errors are calculated. For assay of inhibitor potency (IC50), [γ -32P]ATP is held constant (10 μM), whereas IC261 concentration is varied (0.1, 0.3, 1, 3, and 10 μM). To assess kinetic mechanism, inhibitors are held constant (IC261, 20 μM; IC3608, 100 μM), whereas [γ -32P]ATP is varied as above. For screening small molecule libraries, CK1 isoforms (Ckiα1, δ, and ε) are assayed that casein is used at 10 mg/mL, [γ -32P]ATP is held constant at 2 μM or 1 mM[1].
    数据来源文献[1]. Mashhoon N, et al. Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem. 2000 Jun 30;275(26):20052-60.
    [2]. St?ter M, et al. Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells. Oncogene. 2005 Dec 1;24(54):7964-75.
    [3]. Brockschmidt C, et al. Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo. Gut. 2008 Jun;57(6):799-806.
    单位

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 花香蝶自来 | Solarbio小分子化合物“优秀员工展”第二十六期

      Sulfate (mixture) CAT IB0871 CAS 9041-93-4/11056-06-7 溶解度 Soluble in Water/DMSO ≥5mg/mL 生物 活性 Bleomycin Sulfate是一类水溶性碱性糖肽类抗生素。主要抑制胸腺嘧啶核苷参入DNA,与DNA结合使之破坏分解,作用于增殖细胞周期的S期。可用于抗性筛选和诱导肺纤维化模型。 应用案例   Zhang Y, et al. Biomaterials

    • 体外微核试验原理及注意事项

      配制方法如下: 取上述磷酸盐缓冲液 6.0 mL、镁钾溶液 0.4 mL、葡萄糖- 6 -磷酸钠盐溶液 1.0 mL、辅酶 II 溶液 1.6 mL、肝 S9 组分 1.0 mL,混匀,置冰浴中待用。1.3 肌动蛋白聚合抑制剂细胞松弛素 B(CytochalasinB,cytoB) 溶液用二甲基亚砜 ( DMSO) 配制适当浓度的储备液,避光冷藏保存。cytoB 的终浓度通常为 3 μg/ mL ~6 μg/mL,实验室应根据各种细胞系选择 cytoB 的适当终浓度,以达到理想的双核细胞出现

    • 类器官药物筛选操作方法详解!

      。 d:在 384 孔细胞培养板中用卡铂处理 5 天的类器官的明场图像。显示了用 1 至 40μM 浓度范围卡铂处理的类器官。e:按照本文所述方案进行药物筛选分析的结果示例。显示了用 PIK3CA 抑制剂阿培利司处理的杀伤曲线。曲线显示了来自 13 个不同供体的类器官的反应。误差线表示标准误。 f:对 e 中所示药物筛选数据进行分析后获得的 IC₅₀值。类器官系的颜色编码与 e 中使用的颜色一致。   筛选板分配用类器官溶液的制备   关键提示:开始筛选前,应确认细胞

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1500
    北京索莱宝科技有限公司
    2025年07月11日询价
    询价
    北京诺博莱德科技有限公司
    2025年11月19日询价
    询价
    上海雅心生物技术有限公司
    2026年08月10日询价
    ¥135
    翌圣生物科技(上海)股份有限公司
    2026年07月24日询价
    ¥200
    上海彩佑实业有限公司
    2025年07月14日询价
    II02801 IC261(10mM in DMSO,Sterile) 细胞周期 索莱宝
    ¥1600